Justin J. Leitenberger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Justin J. Leitenberger has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
S. Caleb Freeman
Department of Dermatology, Oregon Health & Science University, Portland, Oregon
3 shared publicationsAnna Bar
Department of Dermatology, Oregon Health & Science University, Portland, Oregon
2 shared publicationsMatthew C. Fox
Department of Dermatology, Dell Medical School, University of Texas at Austin, Austin, Texas
2 shared publicationsMichael S. Heath
Department of Dermatology, Oregon Health & Science University, Portland, Oregon
2 shared publicationsOlivia M. Lucero
Department of Dermatology, Oregon Health & Science University, Portland, Oregon
2 shared publicationsAdeeb Haroon
Department of Dermatology, Oregon Health & Science University, Portland, Oregon
1 shared publication
Latest Publications
- 28 October 2024
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 51 (12) , 1139-1140
Repair of a Multi-subunit Defect on the Nose and Apical Triangle Following Mohs Micrographic Surgery
- 28 October 2024
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 51 (12) , 1139-1140
Repair of a Multi-subunit Defect on the Nose and Apical Triangle Following Mohs Micrographic Surgery
- Open Access
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets
Healthy human skin tissue is often used as a control for comparison to diseased skin in patients with skin pathologies, including skin cancers or other inflammatory conditions such as atopic dermatitis or psoriasis. Although non-affected skin from these patients is a more appropriate choice for comparison, there is a paucity of studies examining such tissue. This lack is exacerbated by the difficulty of processing skin tissue for experimental analysis. In addition, choosing a processing protocol for skin tissue which preserves cell viability and identity while sufficiently dissociating cells for single-cell analysis is not a trivial task. Here, we compare three digestion methods for human skin tissue, evaluating the cell yield and viability for each protocol. We find that the use of a sequential dissociation method with multiple enzymatic digestion steps produces the highest cell viability. Using single-cell sequencing, we show this method results in a relative increase in the proportion of non-antigen-presenting mast cells and CD8 T cells as well as a relative decrease in the proportion of antigen-presenting mast cells and KYNU+ CD4 T cells. Overall, our findings support the use of this sequential digestion method on freshly processed human skin samples for optimal cell yield and viability.
Open AccessOptimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets
Healthy human skin tissue is often used as a control for comparison to diseased skin in patients with skin pathologies, including skin cancers or other inflammatory conditions such as atopic dermatitis or psoriasis. Although non-affected skin from these patients is a more appropriate choice for comparison, there is a paucity of studies examining such tissue. This lack is exacerbated by the difficulty of processing skin tissue for experimental analysis. In addition, choosing a processing protocol for skin tissue which preserves cell viability and identity while sufficiently dissociating cells for single-cell analysis is not a trivial task. Here, we compare three digestion methods for human skin tissue, evaluating the cell yield and viability for each protocol. We find that the use of a sequential dissociation method with multiple enzymatic digestion steps produces the highest cell viability. Using single-cell sequencing, we show this method results in a relative increase in the proportion of non-antigen-presenting mast cells and CD8 T cells as well as a relative decrease in the proportion of antigen-presenting mast cells and KYNU+ CD4 T cells. Overall, our findings support the use of this sequential digestion method on freshly processed human skin samples for optimal cell yield and viability.
- 23 October 2023
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 50 (7) , 663-665
Reconstruction of a Large Scalp Defect
- 23 October 2023
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 50 (7) , 663-665
Reconstruction of a Large Scalp Defect
- 14 September 2023
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 49 (12) , 1139-1142
Tranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair: A Single-Center, Retrospective, Cohort Study
BACKGROUND: Tranexamic acid (TXA) is increasingly being used to prevent hemorrhagic complications after dermatologic surgery. Interpolated flap repairs following Mohs micrographic surgery are at risk for increased bleeding events and unplanned health care utilization, particularly among patients on antithrombotic medication. OBJECTIVE: To assess bleeding events after interpolated flap repair in patients receiving TXA compared with those who did not. MATERIALS AND METHODS: A retrospective review identified interpolated flap repairs in a 5-year period. Hemorrhagic complications were analyzed, defined as major bleeding events, which included all unplanned medical visits, and minor bleeding events, which included any unplanned patient phone calls or messages through electronic medical record. RESULTS: One hundred fifteen patients had interpolated flap repair during the 5-year period, of which 21 (18.3%) received TXA postprocedure. Twenty-seven bleeding events were identified in the non-TXA group compared with 1 event in the TXA-treated group. Patients who received TXA were less likely to have had a bleeding event (28.7% vs 4.8%, p < .01). CONCLUSION: Patients undergoing interpolation flap repair were less likely to experience a bleeding event after subcutaneous injection of TXA.
- 14 September 2023
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 49 (12) , 1139-1142
Tranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair: A Single-Center, Retrospective, Cohort Study
BACKGROUND: Tranexamic acid (TXA) is increasingly being used to prevent hemorrhagic complications after dermatologic surgery. Interpolated flap repairs following Mohs micrographic surgery are at risk for increased bleeding events and unplanned health care utilization, particularly among patients on antithrombotic medication. OBJECTIVE: To assess bleeding events after interpolated flap repair in patients receiving TXA compared with those who did not. MATERIALS AND METHODS: A retrospective review identified interpolated flap repairs in a 5-year period. Hemorrhagic complications were analyzed, defined as major bleeding events, which included all unplanned medical visits, and minor bleeding events, which included any unplanned patient phone calls or messages through electronic medical record. RESULTS: One hundred fifteen patients had interpolated flap repair during the 5-year period, of which 21 (18.3%) received TXA postprocedure. Twenty-seven bleeding events were identified in the non-TXA group compared with 1 event in the TXA-treated group. Patients who received TXA were less likely to have had a bleeding event (28.7% vs 4.8%, p < .01). CONCLUSION: Patients undergoing interpolation flap repair were less likely to experience a bleeding event after subcutaneous injection of TXA.
- Open Access
- 1 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e27534
Efficacy of Abemaciclib in the Management of Refractory Metastatic Extramammary Paget’s Disease
Published systemic therapy options for metastatic extramammary Paget's disease have largely been anecdotal due to the rarity of this disease, which has precluded the ability to conduct clinical trials. We describe the favorable response of a 72-year-old man with extramammary Paget's disease, whose disease has been controlled with the CDK4/6 inhibitor, abemaciclib. The rationale behind the selection of this therapy is discussed.
- 1 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e27534
Open AccessEfficacy of Abemaciclib in the Management of Refractory Metastatic Extramammary Paget’s Disease
Published systemic therapy options for metastatic extramammary Paget's disease have largely been anecdotal due to the rarity of this disease, which has precluded the ability to conduct clinical trials. We describe the favorable response of a 72-year-old man with extramammary Paget's disease, whose disease has been controlled with the CDK4/6 inhibitor, abemaciclib. The rationale behind the selection of this therapy is discussed.
- 11 January 2021
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 48 (3) , 345-347
A Unique Approach to a Common Defect on the Nasal Sidewall and Medial Cheek
An abstract is unavailable. This article is available as a PDF only.
- 11 January 2021
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 48 (3) , 345-347
A Unique Approach to a Common Defect on the Nasal Sidewall and Medial Cheek
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 January 2019
- Published by Elsevier in JAAD Case Reports
- Vol. 5 (1) , 7-11
Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery
- 1 January 2019
- Published by Elsevier in JAAD Case Reports
- Vol. 5 (1) , 7-11
Open AccessKeratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery
- 1 November 2016
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 75 (5) , 1022-1031
Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee
- 1 November 2016
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 75 (5) , 1022-1031
Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee
- Open Access
- 1 November 2015
- Published by Elsevier in JAAD Case Reports
- Vol. 1 (6) , S33-S35
Two cases of trichodysplasia spinulosa responsive to compounded topical cidofovir 3% cream
- 1 November 2015
- Published by Elsevier in JAAD Case Reports
- Vol. 1 (6) , S33-S35
Open AccessTwo cases of trichodysplasia spinulosa responsive to compounded topical cidofovir 3% cream